COVID-19 Pandemic Coverage
XTalks
SEPTEMBER 14, 2020
As of July, the company and its federal partner stated that it is on track to supply between 500 million to 1 billion doses a year at a dose of 100 µg now selected for their Phase III trial. “Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. The price of that prize is incalculable. Moderna’s COVID-19 Vaccine.
92 
Let's personalize your content